Profile
Chi-Feng Chang is currently the Chief Executive Officer at Apexcella Biomedical, Inc., an Independent Director at Tanvex BioPharma, Inc., and a Director at Stembios Technologies, Inc. Previously, Dr. Chang served as the Vice President at Pharmigene, Inc. Dr. Chang holds a doctorate degree from The University of Chicago.
Chi-Feng Chang active positions
| Companies | Position | Start |
|---|---|---|
| TANVEX BIOPHARMA, INC. | Director/Board Member | - |
Stembios Technologies, Inc. | Director/Board Member | - |
Former positions of Chi-Feng Chang
| Companies | Position | End |
|---|---|---|
| PHARMIGENE, INC. | Corporate Officer/Principal | - |
Training of Chi-Feng Chang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmigene, Inc.
Pharmigene, Inc. Pharmaceuticals: GenericHealth Technology Provides genetic based diagnostic solutions | Health Technology |
Tanvex BioPharma, Inc.
Tanvex BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilar medicines to treat neutropenia, breast cancer and metastatic colorectal cancer | Health Technology |
Stembios Technologies, Inc. |
- Stock Market
- Insiders
- Chi-Feng Chang
















